Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Century Clot-Guided Prophylactic Rivaroxaban Therapy for Post ST-Segment Elevation Myocardial Infarction Complicating Left Ventricular Thrombus Compared With Conventional Antiplatelet Therapy

NCT06013020 is registered in ClinicalTrials.gov with Zunyi Medical College as lead sponsor.

NCT NCT06013020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06013020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Century Clot-Guided Prophylactic Rivaroxaban Therapy for Post ST-Segment Elevation Myocardial Infarction Complicating Left Ventricular Thrombus Compared With Conventional Antiplatelet Therapy
Lead sponsor
Zunyi Medical College
Phase
Phase 4
Overall status
Recruiting
Start date
April 1, 2024
Completion date
December 31, 2027
Enrollment
374 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stemi - st elevation myocardial infarction